Topotarget has received the following announcement from its major shareholder the HealthCap funds:
The venture capital fund HealthCap IV is committed to vote in support of the proposed merger between the Danish biotech company Topotarget A/S (NASDAQ OMX: TOPO) and the French oncology company BioAlliance Pharma SA (Euronext Paris: BIO), which was announced on April 16, 2014.
Help employers find you! Check out all the jobs and post your resume.
